SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention after a steep selloff amid no confirmed company update; traders debate whether broad biotech weakness and options-related trading drove the drop or whether the companys prolonged silence is adding pressure. The central catalyst remains the blinded Phase 3 REGAL trial, last reported at 78 of 80 required events: bulls see the slow event pace as a possible sign of longer survival, while bears question the delay, trial design, and prospects for a successful readout.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is drawing attention amid a sharp selloff across semiconductor and AI-linked stocks, with traders debating whether concerns about AI spending, inflation and broader market risk point to further weakness or an oversold pullback. Bulls point to Intels foundry prospects and upcoming earnings, while bears question its valuation and warn the selling may continue.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp futures rebound after Fridays selloff has dominated discussion, pushing back against widespread Black Monday crash fears. Bulls view the move as a relief rally or short squeeze, while skeptics call it a low-volume bull trap and question whether it will hold; some traders also speculate that Russia-related diesel and peace-talk headlines are helping sentiment.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Attention centers on Iovances ESMO data for lifileucel plus pembrolizumab in first-line melanoma, with traders highlighting durable responses and the reported progression-free survival while debating the limits of a small, single-arm cohort and whether the results move beyond earlier data. Sarcoma findings add a potential expansion story, but traders note that larger trials must confirm the signals; many attribute the recent share weakness to a broader biotech selloff rather than a company-specific setback.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp tech- and AI-linked selloff followed by a strong futures rebound, with traders split over whether the bounce signals recovery or is a short-covering rally that could fade. Crash warnings, including Black Monday talk, are competing with optimism ahead of major tech earnings.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention after a sharp semiconductor selloff, amplified by its 3x daily leverage, amid concerns about AI spending and debt, Chinese competition, and persistent inflation. Traders are split between buying the steep dip and expecting a rebound, and warning that selling and forced liquidations may continue.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Deltas quarterly earnings miss and reduced full-year outlook, driven by sharply higher fuel costs, are the main focus. Traders are split over whether strong travel and premium demand can offset margin pressure, with bulls pointing to pricing power and possible fuel relief while bears worry about further earnings weakness.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A sharp selloff across neocloud and AI-infrastructure stocks, driven by worries about debt, financing costs, and whether heavy data-center spending will pay off, is weighing on Nebius. Traders are divided: bears see more downside as the sector faces a valuation reset, while bulls argue Nebius is financially stronger than some peers and the pullback is overdone.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is drawing attention amid continued weakness in Chinese internet stocks, with traders split between buying the oversold pullback and expecting further declines. Bulls cite support levels and Chinas AI potential, while skeptics point to prolonged underperformance versus U.S. tech, weak domestic demand, regulatory and geopolitical risks, and a lack of sustained inflows.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

A sharp AI-sector selloff and concerns about Super Micros governance and export-control risks are driving attention as the stock posts steep losses. Bulls call the decline an oversold buying opportunity and point to expected earnings and AI demand, while bears worry about compliance issues, management credibility, and a possible slowdown in AI spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy?

UNH's Q3 earnings surge and improving margins signal a recovery, but falling membership and elevated utilization raise questions about sustained growth.

Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3?

MOH faces a tough Q3 as declining premiums, shrinking membership and a higher medical care ratio threaten earnings. Can it beat expectations?

Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?

Oscar Health outshines Molina Healthcare with surging membership, stronger earnings growth prospects, a more attractive valuation and robust stock gains.

Analysts Estimate Molina (MOH) to Report a Decline in Earnings: What to Look Out for

Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Centene vs. Molina: Which Managed Care Stock Has More Upside?

CNC's diversified business, improving margins and lower valuation give it an edge over MOH, with stronger earnings prospects and greater upside potential.

Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?

Oscar Health's ACA marketplace expansion fuels growth prospects, but subsidy uncertainty, rising medical costs and pricing risks could challenge lasting profits.

UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock?

UNH's Q3 earnings are expected to jump 41.1% despite revenue headwinds. Can improving cost management and restructuring drive further stock gains?

Oscar Health Trading at a Premium: Why Should You Still Buy It?

Oscar Health's premium valuation reflects surging membership, improving profitability, a scalable tech platform and growth targets through 2027.

$1000 Invested In Molina Healthcare 15 Years Ago Would Be Worth This Much Today

Molina Healthcare (NYSE:MOH) has outperformed the market over the past 15 years by 4.7% on an annualized basis producing an average annual return of 17.92%. Currently, Molina Healthcare has a market capitalization ofread more...

Should Value Investors Buy Molina Healthcare (MOH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

Michael Burry Stays Bullish On VEEV, Calls SNOW 'Overvalued' — And Revisits 'Big Short' Thesis That Best Stocks Fall By Half First

Equity

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$MOH 
 
Reports Q3 after the close Wednesday. Consensus is 72 cents in EPS on 10.93 billion dollars in revenue, down 60.9% and 4.8% from a year ago (Zacks). Membership is expected down 12.7%, with Marketplace down 63%, and the medical care ratio is seen at 93%, up from 92.6% a year ago.

Krypton Research

$MOH Is a buy 👀

Price has tagged off the 200DMA and shown a strong reaction.

I'm happy starting a position, however I still expect a test of the 0.618 fib.

Short term Wave 3 target: 85% 🚀

Markus Heikteotter

$MOH Wants lower 👀

Price has rejected the 0.5 fib for the 2nd time and has lost the trendline.

I expect a move towards the 200DMA next where I'll likely start a position.

Wave 3 target: 117% 🚀

$MOH am liking this lil thang, dancing on the trendy on the hourly .. show me where you want to go, make up your mind and I shall join with my peasant bag ❤️

Feed

News

Sentiment

Earnings

Fundamentals

Info

MOH Molina Healthcare Inc

Fundamentals

Latest MOH News